Current Ratio of UroGen Pharma Ltd. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
UroGen Pharma Ltd. quarterly Current Ratio in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • UroGen Pharma Ltd. Current Ratio for the quarter ending 30 Sep 2025 was 494%, a 34% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

UroGen Pharma Ltd. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 494% -260% -34% 30 Sep 2025
Q2 2025 597% -106% -15% 30 Jun 2025
Q1 2025 702% +130% +23% 31 Mar 2025
Q4 2024 752% +267% +55% 31 Dec 2024
Q3 2024 755% +274% +57% 30 Sep 2024
Q2 2024 703% +253% +56% 30 Jun 2024
Q1 2024 572% +8% +1.4% 31 Mar 2024
Q4 2023 485% -203% -30% 31 Dec 2023
Q3 2023 480% -203% -30% 30 Sep 2023
Q2 2023 451% -230% -34% 30 Jun 2023
Q1 2023 564% -109% -16% 31 Mar 2023
Q4 2022 688% +83% +14% 31 Dec 2022
Q3 2022 683% +69% +11% 30 Sep 2022
Q2 2022 680% +43% +6.8% 30 Jun 2022
Q1 2022 673% +27% +4.2% 31 Mar 2022
Q4 2021 605% -108% -15% 31 Dec 2021
Q3 2021 614% -169% -22% 30 Sep 2021
Q2 2021 637% -236% -27% 30 Jun 2021
Q1 2021 646% -397% -38% 31 Mar 2021
Q4 2020 713% -630% -47% 31 Dec 2020
Q3 2020 782% -630% -45% 30 Sep 2020
Q2 2020 873% -593% -40% 30 Jun 2020
Q1 2020 1043% -390% -27% 31 Mar 2020
Q4 2019 1343% +54% +4.2% 31 Dec 2019
Q3 2019 1412% -64% -4.3% 30 Sep 2019
Q2 2019 1466% 30 Jun 2019
Q1 2019 1433% 31 Mar 2019
Q4 2018 1289% 31 Dec 2018
Q3 2018 1476% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.